Illumina, Inc. (ILMN)
NASDAQ: ILMN · IEX Real-Time Price · USD
124.68
+1.63 (1.32%)
At close: May 1, 2024, 4:00 PM
126.00
+1.32 (1.06%)
After-hours: May 1, 2024, 7:40 PM EDT
Illumina Revenue
In the year 2023, Illumina had annual revenue of $4.50B, a decrease of -1.75%. Revenue in the quarter ending December 31, 2023 was $1.12B with 3.60% year-over-year growth.
Revenue (ttm)
$4.50B
Revenue Growth
-1.75%
P/S Ratio
4.40
Revenue / Employee
$337,126
Employees
13,360
Market Cap
19.81B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4.50B | -80.00M | -1.75% |
Jan 1, 2023 | 4.58B | 58.00M | 1.28% |
Jan 2, 2022 | 4.53B | 1.29B | 39.73% |
Jan 3, 2021 | 3.24B | -304.00M | -8.58% |
Dec 29, 2019 | 3.54B | 210.00M | 6.30% |
Dec 30, 2018 | 3.33B | 581.00M | 21.11% |
Dec 31, 2017 | 2.75B | 354.00M | 14.76% |
Jan 1, 2017 | 2.40B | 178.00M | 8.02% |
Jan 3, 2016 | 2.22B | 358.64M | 19.27% |
Dec 28, 2014 | 1.86B | 440.18M | 30.97% |
Dec 29, 2013 | 1.42B | 272.66M | 23.74% |
Dec 30, 2012 | 1.15B | 92.98M | 8.81% |
Jan 1, 2012 | 1.06B | 152.79M | 16.93% |
Jan 2, 2011 | 902.74M | 236.42M | 35.48% |
Jan 3, 2010 | 666.32M | 93.10M | 16.24% |
Dec 28, 2008 | 573.23M | 206.43M | 56.28% |
Dec 30, 2007 | 366.80M | 182.21M | 98.71% |
Dec 31, 2006 | 184.59M | 111.09M | 151.13% |
Jan 1, 2006 | 73.50M | 22.92M | 45.31% |
Jan 2, 2005 | 50.58M | 22.55M | 80.43% |
Dec 28, 2003 | 28.04M | 18.00M | 179.23% |
Dec 29, 2002 | 10.04M | 7.55M | 303.86% |
Dec 30, 2001 | 2.49M | 1.18M | 89.92% |
Dec 31, 2000 | 1.31M | 835.00K | 176.16% |
Dec 31, 1999 | 474.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Molina Healthcare | 35.85B |
Baxter International | 14.81B |
STERIS | 5.41B |
BioNTech SE | 4.24B |
Hologic | 3.97B |
Align Technology | 3.86B |
The Cooper Companies | 3.67B |
Waters | 2.96B |
ILMN News
- 19 days ago - Illumina's planned divestment of GRAIL approved by the European Commission - PRNewsWire
- 19 days ago - EU approves Illumina's plan to divest cancer test maker Grail - Reuters
- 22 days ago - Illumina CFO Goswami to depart, Summit Therapeutics' Dhingra named successor - Reuters
- 22 days ago - Illumina appoints Ankur Dhingra Chief Financial Officer, Jakob Wedel Chief Strategy and Corporate Development Officer - PRNewsWire
- 27 days ago - Illumina to Announce First Quarter 2024 Financial Results on Thursday, May 2, 2024 - PRNewsWire
- 6 weeks ago - EU court should back Illumina's appeal against EU review of Grail deal, court adviser says - Reuters
- 7 weeks ago - Exclusive: Icahn drops Illumina board challenge threat, sources say - Reuters
- 2 months ago - Illumina forecasts flat 2024 sales as sluggish demand drags on - Reuters